Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: EN Paris
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

ADOC:FP

67.6100 EUR 1.4000 2.03%

As of 11:38:28 ET on 06/02/2015.

Company Profile for Adocia (ADOC)

Adocia SAS is a biotechnology company. The Company researches and develops protein delivery products for wound healing and tissue regeneration based on growth factors. Adocia is specialized in insulin therapy and the treatment of the diabetic foot ulcer, one of the main complications of diabetes.

Contact Information

Adocia

115 avenue Lacassagne
Lyon, 69003
France
Phone: 33-4-72-61-06-10
Fax: 32-4-72-36-39-67

Key Executives for Adocia (ADOC)

Gerard SoulaChairman/CEOValerie DanaguezianChief Financial Officer
Olivier SoulaDir:R&D/Deputy Gen MgrRemi SoulaDir:Business Development

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil